UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023962
Receipt number R000027510
Scientific Title Efficacy of the criterion of sarcopenia in chronic liver disease
Date of disclosure of the study information 2016/09/06
Last modified on 2021/07/20 20:01:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of the criterion of sarcopenia in chronic liver disease

Acronym

Sarcopenia in chronic liver disease

Scientific Title

Efficacy of the criterion of sarcopenia in chronic liver disease

Scientific Title:Acronym

Sarcopenia in chronic liver disease

Region

Japan


Condition

Condition

Chronic liver disesase

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy of the criterion of the sarcopenia in chronic liver disease

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of the survival span of patient with sarcopenia and non-sarcopenia

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) chronic liver disease
2) Cases obtained written informed consent

Key exclusion criteria

1) Cases regarded by doctors as inappropriate for the enrollment for some reasons

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Uojima
Middle name
Last name Haruki

Organization

Kitasato University school of medicine

Division name

Department of Gastroenterology

Zip code

252-0375

Address

1-15-1 Kitasato Minami Sagamihara Kanagawa 252-0374 Japan

TEL

+81-42-778-8111

Email

kiruha555@yahoo.co.jp


Public contact

Name of contact person

1st name Haruki
Middle name
Last name Uojima

Organization

Kitasato University School of Medicine

Division name

Department of Gastroenterology

Zip code

252-0375

Address

1-15-1 Kitasato Minami Sagamihara Kanagawa 252-0374 Japan

TEL

+81-42-778-8111

Homepage URL


Email

kiruha555@yahoo.co.jp


Sponsor or person

Institute

Kitasato University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Kitasato University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kitasato institute hospital research ethics committee

Address

1-15-1 Kitasato Minami Sagamihara Kanagawa 252-0374 Japan

Tel

+81-42-778-8111

Email

mailtorinri@med.kitasato-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 06 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

300

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 07 Month 01 Day

Date of IRB

2016 Year 09 Month 01 Day

Anticipated trial start date

2016 Year 09 Month 01 Day

Last follow-up date

2021 Year 04 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The new JSH criteria for sarcopenia are accurate predictors of poor prognosis in patients with liver cirrhosis.


Management information

Registered date

2016 Year 09 Month 06 Day

Last modified on

2021 Year 07 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027510


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name